数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 11867.38万股，累计占流通股比： 23.36%，较上期变化： 632.89万股。 一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.1085 | -0.1323 | 182.01 | -1.4372 | | 每股净资产（元） | 2.51 | 2.54 | -1.18 | 2.67 | | 每股公积金(元) | 2.25 | 2.25 | 0 | 2.25 | | 每股未分配利润(元) | -0.85 | -0.96 | 11.46 | -0.83 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 19.4 | 19.69 | -1.47 | 29.17 | | 净利润(亿元) | 0.55 | -0.68 | 180.88 | -7.42 | | 净资产收益率(%) | 4.24 | - ...

Financial Data and Indicators - The basic earnings per share for Q1 2025 is 0.0900 CNY, unchanged from Q1 2024, but down from 0.3900 CNY in Q1 2023 [1] - The net asset per share decreased to 10.39 CNY in Q1 2025, a decline of 6.73% compared to 11.14 CNY in Q1 2024 and significantly down from 16.35 CNY in Q1 2023 [1] - The undistributed profits per share fell by 22.26% to 2.55 CNY in Q1 2025 from 3.28 CNY in Q1 2024, and down from 4.38 CNY in Q1 2023 [1] - The operating revenue for Q1 2025 was 39.19 billion CNY, a decrease of 7.74% from 42.48 billion CNY in Q1 2024 and down from 43.9 billion CNY in Q1 2023 [1] - The net profit for Q1 2025 increased to 0.48 billion CNY, a growth of 6.67% compared to 0.45 billion CNY in Q1 2024, but significantly lower than 2.04 billion CNY in Q1 2023 [1] - The return on equity (ROE) improved to 0.89% in Q1 2025 from 0.79% in Q1 2024, and up from 3.49% in Q1 2023 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 98.187 million shares, accounting for 34.47% of the circulating shares, with an increase of 4.9279 million shares compared to the previous period [1] - The largest shareholder, Shanghai Tuopai Private Fund Management Co., Ltd., holds 24.9849 million shares, representing 8.77% of the total share capital, with a decrease of 76.97% [2] - Shenzhen Yingfu Huizhi Private Securities Fund Co., Ltd. remains unchanged with 17.2606 million shares, accounting for 6.06% [2] - New entrants in the top ten shareholders include Zhongye Zhengqi (Beijing) International Investment Co., Ltd. with 7.1991 million shares (2.53%), and Morgan Emerging Power Mixed A Class with 4.5295 million shares (1.59%) [2] - Several shareholders exited the top ten list, including Shanghai Guosheng Capital Management Co., Ltd. and Haining Wanxing Enterprise Management Center [3] Dividend Distribution - The company has decided not to distribute dividends or transfer shares in this period [4]

广东德美精细化工集团股份有限公司的主营业务是从事纺织化学品、皮革化学品及塔拉产品、石油精细 化学等产品的研发、生产及销售，同时为客户提供专业的技术支持和服务。公司的主要产品是纺织化学 品、皮革化学品、塔拉产品、石油化学品。 最新一期业绩显示，2024年年报，公司实现营业收入30.56亿元，同比-0.69%；净利润6098.86万元，同 比101.07%，销售毛利率23.79%。 4月28日，德美化工今日收盘6.14元，下跌5.54%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到48.54倍，总市值29.60亿元。 从行业市盈率排名来看，公司所处的化学制品行业市盈率平均51.06倍，行业中值41.06倍，德美化工排 名第117位。 资金流向方面，4月28日，德美化工主力资金净流出2467.96万元，近5日总体呈流入状态，5日共流入 6134.39万元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)117德美化工48.5448.541.2129.60亿行业平均 51.0654.383.8775.11亿行业中值41.0638.752.1438.42亿1宏柏新材-5347.4853.561. ...

本次公司不分配不转赠。 前十大流通股东累计持有： 1207.37万股，累计占流通股比： 8.39%，较上期变化： -1296.72万股。 | 名称 | 持有数量(万股) | 占总股本比例(%) | 增减情况(万股) | | --- | --- | --- | --- | | 多国东 | 206.05 | 1.43 | 104.12 | | J. P. Morgan Securities PLC-自有资金 | 204.46 | 1.42 | 新进 | | 沈夏青 | 201.00 | 1.40 | 55.74 | | 无锡市金禾创业投资有限公司 | 175.32 | 1.22 | 不变 | | 金素 | 94.70 | 0.66 | 新进 | | BARCLAYS BANK PLC | 85.01 | 0.59 | 新进 | | 汤文达 | 83.41 | 0.58 | 新进 | | 国联低碳经济3个月持有混合A | 62.20 | 0.43 | 新进 | | 李碧凡 | 51.89 | 0.36 | 新进 | | 王猛 | 43.33 | 0.30 | 新进 | | 较上个报告期退出前十大股东有 | | | ...

一、主要会计数据和财务指标 数据四舍五入，查看更多财务数据>> | 名称 | 持有数量(万股) | 占总股本 | 增减情况 | | --- | --- | --- | --- | | | | 比例(%) | (万股) | | 天津利安隆（300596）科技集团有限公司 | 3246.13 | 14.45 | 不变 | | 利安隆国际集团有限公司 | 2505.92 | 11.15 | 不变 | | 天津聚鑫隆股权投资基金合伙企业(有限合伙) | 1578.44 | 7.03 | 不变 | | 天津圣金隆企业管理合伙企业(有限合伙) | 624.46 | 2.78 | 不变 | | 韩厚义 | 458.00 | 2.04 | -8.30 | | 天津利安隆新材料股份有限公司-第三期员工持股计划 | 405.24 | 1.80 | 不变 | | 红杉锦程(厦门)股权投资合伙企业(有限合伙) | 333.98 | 1.49 | 不变 | | 韩谦 | 333.00 | 1.48 | -22.00 | | 天津融创私募股权投资基金管理有限公司-天津海河融创津京 | | | | | 冀智能产业基金合伙企业(有限合伙) ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company's revenue growth is recovering, driven primarily by its main business of vacuum insulation panels, which achieved a revenue of 915 million yuan in 2024, reflecting a year-on-year increase of 11.4% [8] - The gross profit margin is under pressure due to a decrease in export sales and rising costs, with the overall gross margin for 2024 at 29.1%, down 3.9 percentage points year-on-year [8] - The company is actively expanding production capacity and optimizing product processes, with significant investments in fixed and intangible assets [8] Financial Performance Summary - Total revenue for 2024 is projected at 933.54 million yuan, with a year-on-year growth of 11.16% [1] - The net profit attributable to shareholders for 2024 is expected to be 77.16 million yuan, a decrease of 27.27% year-on-year [1] - Earnings per share (EPS) for 2024 is estimated at 0.46 yuan, with a price-to-earnings (P/E) ratio of 31.43 [1] Revenue and Profit Forecast - Revenue is expected to grow to 1,138.94 million yuan by 2025, with a year-on-year increase of 22% [1] - The net profit attributable to shareholders is forecasted to recover to 97.92 million yuan in 2025, representing a growth of 26.90% [1] - The projected EPS for 2025 is 0.58 yuan, with a P/E ratio of 24.76 [1] Market Data - The closing price of the stock is 14.45 yuan, with a market capitalization of approximately 2,424.91 million yuan [5] - The stock has a price-to-book (P/B) ratio of 2.35 [5] Operational Insights - The company is focusing on new application development, particularly in the field of battery insulation, which is expected to drive future growth [8] - The company is also working on the installation and debugging of new production equipment, aiming for trial production in the first half of 2025 [8]

Investment Rating - The report maintains a "Buy" rating for the company [5] Core Views - The company achieved a revenue of 13.65 billion yuan in 2024, representing a year-on-year growth of 17.61%, and a net profit attributable to shareholders of 898 million yuan, up 25.39% year-on-year [1] - The mining service business generated revenue of 10.81 billion yuan in 2024, with a gross margin of 17.72%, and saw significant growth in both domestic and international markets [1][2] - The defense equipment segment reported a revenue of 350 million yuan, reflecting a substantial year-on-year increase of 47.74% [3] - The company is focused on enhancing its market position through strategic acquisitions and international expansion, particularly in the mining and explosives sectors [4] Summary by Sections Mining Service Business - Revenue reached 10.81 billion yuan in 2024, with a year-on-year growth of 21.01% and a gross margin increase of 0.9 percentage points [1] - The company is expanding its international presence, particularly in South America and South Africa, and is establishing production facilities in Zambia and Peru [1] Explosives Business - Revenue for the explosives segment was 2.31 billion yuan in 2024, with a slight year-on-year growth of 1.18% and a gross margin of 36.5% [2] - The company is actively pursuing acquisitions to enhance its production capacity and market share, particularly in the Xinjiang region [2] Defense Equipment Segment - The defense equipment segment achieved a revenue of 350 million yuan in 2024, driven by a recovery in military demand and increased delivery volumes [3] - The company is enhancing its product offerings through autonomous production lines and strategic partnerships in the defense sector [3] Strategic Development - The company aims to become a leading global player in mining services, explosives production, and defense equipment [4] - It plans to integrate its mining and explosives services, focusing on key markets along the Belt and Road Initiative [4] - The company is also increasing its stake in the Guangdong Provincial Military Industry Group, which is expected to enhance its capabilities in the defense sector [4] Financial Projections - The company forecasts net profits of 1.10 billion yuan, 1.33 billion yuan, and 1.62 billion yuan for 2025, 2026, and 2027, respectively, with corresponding P/E ratios of 22X, 18X, and 15X [4]

Shareholding Reduction Announcements - MEI TUNG (CHINA) LIMITED plans to reduce its shareholding in Helen Zhe by up to 22.09 million shares, representing 2.12% of the total share capital after excluding repurchased shares [1] - Shandong Railway Development Fund plans to reduce its shareholding in Century Rui Er by up to 17.55 million shares, representing 3% of the total share capital [1] - Wu Baigeng plans to reduce his shareholding in Pinwo Food by up to 2.97 million shares, representing 3% of the total share capital [1] - Huayuan International Land Port Group plans to reduce its shareholding in Phoenix Shipping by up to 30.36 million shares, representing 3% of the total share capital [3] Financial Performance Reports - United Chemical reported a revenue of 535 million yuan for 2024, a year-on-year increase of 24.80%, and a net profit of 56.43 million yuan, up 66.81% [5] - Huitong Technology achieved a revenue of 662 million yuan, a year-on-year increase of 11.84%, and a net profit of 108 million yuan, up 9.30% [7] - Guangji Pharmaceutical reported a revenue of 639 million yuan, a year-on-year decrease of 13.42%, and a net loss of 295 million yuan [8] - Anshuo Information achieved a revenue of 990 million yuan, a year-on-year increase of 11.53%, and a net profit of 15.09 million yuan, up 132.78% [9] - Yifan Pharmaceutical reported a revenue of 5.16 billion yuan, a year-on-year increase of 26.84%, and a net profit of 386 million yuan, up 170.04% [10] - Hongri Pharmaceutical reported a revenue of 5.78 billion yuan, a year-on-year decrease of 5.34%, and a net profit of 21.47 million yuan, down 95.76% [11] - Zhonglan Environmental reported a revenue of 646 million yuan, a year-on-year decrease of 22.75%, and a net profit of 13.10 million yuan, down 36.12% [13] - Feilu Co. reported a revenue of 518 million yuan, a year-on-year decrease of 37.16%, and a net loss of 140 million yuan [14] - China Great Wall reported a revenue of 14.20 billion yuan, a year-on-year increase of 5.83%, and a net loss of 1.48 billion yuan [15] - Nanshan A reported a revenue of 15.45 billion yuan, a year-on-year decrease of 15.06%, and a net profit of 267 million yuan, down 83.89% [16] - Yawen Co. reported a revenue of 2.06 billion yuan, a year-on-year increase of 6.70%, and a net profit of 75 million yuan, down 24.13% [17] - Jinlong Co. reported a revenue of 663 million yuan, a year-on-year increase of 245.16%, and a net loss of 89.23 million yuan [18] - Nanshan Holdings reported a revenue of 8.40 billion yuan, a year-on-year decrease of 30.35%, and a net loss of 1.77 billion yuan [20] - Hengfeng Information reported a revenue of 227 million yuan, a year-on-year decrease of 53.07%, and a net loss of 86.80 million yuan [21] - Wantong Technology reported a revenue of 1.21 billion yuan, a year-on-year increase of 19.58%, and a net profit of 36.92 million yuan, up 147.08% [22] - Kehua Bio reported a revenue of 1.76 billion yuan, a year-on-year decrease of 27.55%, and a net loss of 641 million yuan [23] - Dongfang Tower reported a revenue of 4.20 billion yuan, a year-on-year increase of 4.79%, and a net profit of 564 million yuan, down 10.97% [24] - Yanpai Co. reported a revenue of 785 million yuan, a year-on-year increase of 8.75%, and a net profit of 42.18 million yuan, down 35.72% [25] - Yongli Co. reported a revenue of 2.24 billion yuan, a year-on-year increase of 10.69%, and a net profit of 22.30 million yuan, down 40.73% [26]

Core Insights - Despite an 11.88% year-on-year decline in revenue to 5.677 billion yuan, the company achieved a significant profit rebound, with total profit increasing by 159.94% to 241 million yuan and net profit attributable to shareholders rising by 122.17% to 103 million yuan, successfully reversing previous losses [1] - The company aims to become a global leader in chemical and technology solutions, focusing on differentiated development and enhancing core competitiveness through a strategy of "focus, foresight, and alliances" [1] Business Segments - The crop protection segment remains the core pillar, contributing 3.590 billion yuan, accounting for 63.25% of total revenue. The company has established a supply chain system covering the entire product lifecycle through its production bases in China, the UK, and Malaysia [2] - The pharmaceutical CDMO segment generated revenue of 1.285 billion yuan, benefiting from the growing demand for outsourced R&D in innovative drugs. The company has formed partnerships with several leading pharmaceutical firms and is expanding its CRO platform [2] Future Strategy - The company plans to expand mature businesses, including small molecule CDMO, starting materials, GMP intermediates, and advanced raw materials. It will also invest in emerging businesses such as peptide CDMO and radioactive drug-related CDMO [3] - Despite revenue pressures, the company maintains a strong commitment to R&D, with R&D expenses reaching 291 million yuan, accounting for 5.13% of revenue. The company holds 160 domestic and international invention patents [3] International Strategy - The company's overseas strategy is proactive, with the UK base serving as a gateway to the European market and the Malaysian project as a key foothold in Southeast Asia. This multi-regional capacity configuration reduces geopolitical risks and allows for customized solutions based on client needs [3] Shareholder Returns - The company returned nearly 98 million yuan to shareholders through cash dividends and share buybacks, representing 94.84% of net profit, demonstrating management's commitment to investor returns [4] - The company has implemented a mechanism for shared interests between shareholders and employees, binding core talent through capital increases and employee stock ownership plans [4] Outlook - The company is positioned for a higher quality leap as a "chemical solutions provider," warranting continued market attention [5]

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expectation that the company's stock will outperform the benchmark index by more than 20% over the next 6-12 months [2][5][7]. Core Views - The company reported a total revenue of RMB 15.88 billion for 2024, a year-on-year increase of 3.79%, with a net profit attributable to shareholders of RMB 2.03 billion, up 32.36% year-on-year. The fourth quarter alone saw a revenue of RMB 5.27 billion, reflecting a 17.90% increase year-on-year and a 44.29% increase quarter-on-quarter [5][10][11]. - The dye industry is expected to recover, and the company is anticipated to benefit from increased sales of various chemical products and ongoing real estate projects, supporting the "Buy" rating [5][7][10]. Financial Summary - The company’s revenue for 2024 was RMB 15,883.86 million, with a growth rate of 3.79% compared to 2023. The EBITDA for 2024 was RMB 2,900 million, and the net profit was RMB 2,354.86 million, marking a 35.88% increase year-on-year [11][15]. - The earnings per share (EPS) for 2024 is projected at RMB 0.62, with a slight adjustment in forecasts for 2025-2026, expecting EPS of RMB 0.63 and RMB 0.71 respectively [7][15]. - The company’s gross margin for 2024 was 27.87%, an increase of 1.74 percentage points year-on-year, indicating improved profitability despite challenges in the dye market [10][11]. Business Segments - The dye and intermediate business showed resilience, with revenue from the dye segment reaching RMB 75.91 billion in 2024, a 0.94% increase year-on-year, despite a 5.81% decline in average price per ton [10][11]. - The real estate segment saw significant growth, with revenue of RMB 24.82 billion, up 87.26% year-on-year, driven by project deliveries [10][11]. - The company has a strong market position in the dye industry, with a production capacity of 300,000 tons per year, and is expanding its intermediate product offerings to enhance its competitive edge [10][11].